CIG Implements Discrete Optics With Mindspeed's Burst-Mode Laser Driver to Cost Reduce Optical Network Terminals

Mindspeed Technologies, Inc. (NASDAQ: MSPD), a leading supplier of semiconductor solutions for network infrastructure applications, today announced that Mindspeed's M02090 laser driver with integrated limiting amplifier and M02015 high sensitivity transimpedance amplifier (TIA) have enabled Cambridge Industries Group (CIG) to implement a bi-directional optical sub-assembly (BOSA) on-board design in dual closed loop configuration, significantly reducing the cost of optical network terminals (ONTs) for fiber-to-the-premise (FTTP) applications.

Mindspeed's M02090 integrates a burst-mode laser driver with a limiting amplifier to deliver up to 2.5 Gbps data rates, addressing Gigabit Ethernet PON (GEPON) and Gigabit PON (GPON) applications. The device incorporates a proprietary dual closed loop technology that reduces system cost by providing real-time monitoring of, and compensation for, laser aging and temperature effects.

The M02015 high-sensitivity TIA features a high accuracy isolated current monitoring output, making it ideal for use with avalanche photodetectors. "By implementing the BOSA on-board with the M02015, we were able to reduce our bill of materials and with Mindspeed's M02090 based dual closed loop solution, we were able to further eliminate costs by improving laser operation while lowering production testing," said Gerald Wong, chief executive officer at CIG. "Thus allowing us to pass on the savings to our GPON ONT customers and accelerate the deployment of FTTP passive optical networks."

"We are pleased to enable industry innovators like CIG to lower the cost of their ONTs and facilitate the mass adoption and deployment of passive optical networks," said Hasnain Bajwa, Mindspeed's senior vice president and general manager, lightspeed connectivity solutions.

The M02090 and M02015 are fully qualified and shipping in production volume for FTTP applications.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.